Skip to main content
CDLX
NASDAQ Technology

Cardlytics Seeks Shareholder Approval for Reverse Stock Split to Avoid Nasdaq Delisting

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$0.983
Mkt Cap
$53.32M
52W Low
$0.664
52W High
$3.28
Market data snapshot near publication time

Summary

Cardlytics is seeking shareholder approval for a reverse stock split (1-for-5 to 1-for-15) to meet Nasdaq's minimum bid price requirement and avoid delisting, following a year of significant revenue decline and impairment.


Key Events

  • Shareholder Vote on Reverse Stock Split

    Shareholders will vote on a proposal to effect a reverse stock split of common stock at a ratio ranging from 1-for-5 to 1-for-15, with the Board of Directors having discretion over the final ratio.

  • Aims to Maintain Nasdaq Listing

    The primary purpose of the reverse stock split is to increase the per-share price to meet Nasdaq's $1.00 minimum bid price requirement and avoid potential delisting, a critical step given the current stock price of $0.98.

  • Addresses Prior Underperformance

    This proposal comes after the company reported a 16% revenue decline and a $49.1 million goodwill impairment in its 2025 Annual Report, highlighting the financial challenges leading to the need for this action.

  • Routine Governance Matters

    Other proposals include the election of three Class II directors (Amit Gupta, Jack Klinck, Srishti Gupta), the ratification of Deloitte & Touche LLP as the independent auditor, and an advisory vote on executive compensation.


Analysis

Cardlytics, Inc. has filed its definitive proxy statement (DEF 14A) for its Annual Meeting on May 20, 2026. The most significant proposal is a request for shareholder approval to amend the company's charter to effect a reverse stock split at a ratio between 1-for-5 and 1-for-15. This action is primarily aimed at increasing the per-share market price of the common stock to meet Nasdaq's minimum bid price requirement of $1.00, thereby preventing delisting. The need for a reverse stock split follows a challenging period, as indicated by the company's 2025 revenue decline of 16% and a $49.1 million goodwill impairment, as reported in its recent 10-K. While a reverse split is a necessary step to maintain listing and potentially improve marketability, it reflects significant past stock underperformance and carries risks, including no guarantee of a sustained price increase or improved liquidity. The Board will have discretion over the exact ratio and implementation. Other proposals include the routine election of three Class II directors, ratification of Deloitte & Touche LLP as the independent auditor, and an advisory vote on executive compensation.

At the time of this filing, CDLX was trading at $0.98 on NASDAQ in the Technology sector, with a market capitalization of approximately $53.3M. The 52-week trading range was $0.66 to $3.28. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDLX - Latest Insights

CDLX
Jun 03, 2026, 4:34 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.620
Real-time Price: $5.41 info
Change: +$4.79 (+773%) info
Market Cap: $31.421M info
CDLX
Jun 03, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6499
Real-time Price: $5.41 info
Change: +$4.76 (+732%) info
Market Cap: $31.421M info
CDLX
May 20, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7251
Real-time Price: $5.41 info
Change: +$4.68 (+646%) info
Market Cap: $31.421M info
CDLX
May 19, 2026, 4:21 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.596
Real-time Price: $5.41 info
Change: +$4.81 (+808%) info
Market Cap: $31.421M info
CDLX
May 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6752
Real-time Price: $5.41 info
Change: +$4.73 (+701%) info
Market Cap: $31.421M info
CDLX
May 07, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.850
Real-time Price: $5.41 info
Change: +$4.56 (+536%) info
Market Cap: $31.421M info
CDLX
May 07, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.849
Real-time Price: $5.41 info
Change: +$4.56 (+537%) info
Market Cap: $31.421M info
CDLX
May 07, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.820
Real-time Price: $5.41 info
Change: +$4.59 (+560%) info
Market Cap: $31.421M info
CDLX
Apr 09, 2026, 4:10 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $0.9821
Real-time Price: $5.41 info
Change: +$4.43 (+451%) info
Market Cap: $31.421M info
CDLX
Apr 09, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.9829
Real-time Price: $5.41 info
Change: +$4.43 (+450%) info
Market Cap: $31.421M info